Trilogy Capital
ALAB icon

Trilogy Capital’s Astera Labs ALAB Stock Holding History

Trilogy Capital’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01M Buy
2,850
+100
+4% +$32.2K 0.04% 208
2026
Q2 		$1.33M Sell
2,750
-3,850
-58% -$1.02M 0.05% 182
2026
Q1 		$723K Buy
6,600
+1,249
+23% +$178K 0.03% 222
2025
Q4 		$890K Buy
5,351
+1,650
+45% +$276K 0.04% 199
2025
Q3 		$725K Sell
3,701
-399
-10% -$65.6K 0.03% 208
2025
Q2 		$371K Buy
+4,100
New +$324K 0.02% 268

Other funds holding ALAB

Salem Investment Counselors
Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Oak Grove Capital
Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return
Counterpoint Mutual Funds
Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

Trilogy Capital's ALAB Position: Q3 2026 in Review

Trilogy Capital increased its Astera Labs (ALAB) stake by 3.6% in Q3 2026, buying an estimated $32.2K and bringing the position to 2,850 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #208.

Trilogy Capital first reported a position in ALAB in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.33M in Q2 2026. 175 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Trilogy Capital held 2,850 shares of Astera Labs worth $1.01M as of Q3 2026.
  • Trilogy Capital bought 100 Astera Labs shares in Q3 2026, an estimated $32.2K.
  • Astera Labs made up 0.04% of Trilogy Capital's portfolio in Q3 2026, its #208 holding.
  • Trilogy Capital first reported a position in Astera Labs in Q2 2025 and has held it in 6 quarters since.
  • Trilogy Capital's Astera Labs position peaked at $1.33M in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.